Galapagos looking for acquisitions after drug deal

AMSTERDAM Wed Feb 29, 2012 4:49am EST

Related Topics

AMSTERDAM (Reuters) - Galapagos is looking for acquisitions after it received $150 million euros in upfront payments from a deal with U.S. Abbott Laboratories (ABT.N) for its leading drug.

"It would have to fit into what we are already doing and make financial sense," Chief Executive Onno van de Stolpe told a news conference on Wednesday.

(Reporting by Anthony Deutsch, writing by Ben Deighton)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.